Therapeutic Asset Ratings
567 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nivolumab
Unresectable Malignant Solid Neoplasm
Fred Hutchinson Cancer Center
P2
B
(60)
Pembrolizumab
Malignant Renal Pelvis Neoplasm
Fred Hutchinson Cancer Center
P2
B
(60)
Pembrolizumab
Unresectable Ureter Urothelial Carcinoma
Fred Hutchinson Cancer Center
P2
B
(60)
PREDNISONE TABLETS
Prostate Small Cell Carcinoma
Fred Hutchinson Cancer Center
P2
B
(60)
Thiotepa
Hematopoietic And Lymphoid System Neoplasm
Fred Hutchinson Cancer Center
P2
B
(60)
CYCLOSPORIN A
Lymphoplasmacytic Lymphoma
Fred Hutchinson Cancer Center
P2
B
(59)
CYCLOSPORIN A
Mixed Phenotype Acute Leukemia
Fred Hutchinson Cancer Center
P2
B
(59)
Jcar017 (Lisocabtagene Maraleucel)
High Grade B-Cell Lymphoma
Fred Hutchinson Cancer Center
P2
B
(59)
Anti-Thymoglobulin, Rabbit
Hematopoietic And Lymphoid System Neoplasm
Fred Hutchinson Cancer Center
P3
B
(58)
Thiotepa
Mixed Phenotype Acute Leukemia
Fred Hutchinson Cancer Center
P3
B
(58)
Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs
Acute Leukemia
Fred Hutchinson Cancer Center
P2
B
(58)
Anti-Thymoglobulin, Rabbit
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Fred Hutchinson Cancer Center
P2
B
(58)
Bendamustine
Prostate Carcinoma
Fred Hutchinson Cancer Center
P2
B
(58)
Cladribine
Acute Leukemia Of Ambiguous Lineage
Fred Hutchinson Cancer Center
P2
B
(58)
Idarubicine
Acute Leukemia Of Ambiguous Lineage
Fred Hutchinson Cancer Center
P2
B
(58)
Idarubicine
Myeloproliferative Neoplasm
Fred Hutchinson Cancer Center
P2
B
(58)
Monomethyl Fumarate
Acute Leukemia of Ambiguous Lineage
Fred Hutchinson Cancer Center
P2
B
(58)
Nivolumab
Head And Neck Squamous Cell Carcinoma
Fred Hutchinson Cancer Center
P2
B
(58)
Vorinostat
Prostate Adenocarcinoma
Fred Hutchinson Cancer Center
P2
B
(58)
Zofran
Prostate Cancer
Fred Hutchinson Cancer Center
P4
B
(57)
Anti-Thymoglobulin, Rabbit
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer Center
P2
B
(57)
Busulphan
CD4+/CD56+ Hematodermic Neoplasm
Fred Hutchinson Cancer Center
P2
B
(57)
Cyclophosphamide
Burkitt Leukemia
Fred Hutchinson Cancer Center
P2
B
(57)
Decitabine
Mixed Phenotype Acute Leukemia
Fred Hutchinson Cancer Center
P2
B
(57)
FILGRASTIM
Autoimmune Disease
Fred Hutchinson Cancer Center
P2
B
(57)
Showing 201 to 225 of 567 assets
Previous
Page 9 of 23
Next